Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

128.45 -0.93 (-0.72%)
Streaming Delayed Price Updated: 3:19 PM EDT, Apr 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,886,249
Open 129.27
Bid (Size) 128.43 (2)
Ask (Size) 128.47 (2)
Prev. Close 129.38
Today's Range 127.23 - 129.53
52wk Range 99.71 - 141.23
Shares Outstanding 1,750,942,289
Dividend Yield 1.84%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What To Expect From Penumbra’s (PEN) Q1 Earnings
Medical device company Penumbra (NYSE:PEN) will be reporting results tomorrow after the bell. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Earnings To Watch: ResMed (RMD) Reports Q1 Results Tomorrow
Medical device company ResMed (NYSE:RMD) will be announcing earnings results tomorrow after market close. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence

Performance

YTD
+13.23%
+13.23%
1 Month
+2.27%
+2.27%
3 Month
+4.24%
+4.24%
6 Month
+10.22%
+10.22%
1 Year
+20.17%
+20.17%

More News

Read More
What To Expect From Boston Scientific’s (BSX) Q1 Earnings
Via StockStory
Topics Economy
Exposures Interest Rates
Earnings To Watch: Intuitive Surgical (ISRG) Reports Q1 Results Tomorrow
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Dividend Stock Analysis: Abbott Laboratories
Via Talk Markets
Topics Stocks / Equities
These Analysts Boost Their Forecasts On Abbott Laboratories After Better-Than-Expected Earnings
Via Benzinga
Demystifying Abbott Laboratories: Insights From 11 Analyst Reviews
Via Benzinga
5 Dividend Aristocrats® So Good You'll Never Want to Sell
Via The Motley Fool
Tariff-Resistant Abbott Laboratories on Track for New Highs
Via MarketBeat
Topics World Trade
Exposures COVID-19 Tariff
US Stocks Likely To Open Higher Ahead Of Festive Weekend: 'Current Equity Levels Offer An Attractive Entry Opportunity'
Via Benzinga
Nasdaq Dips 3% Amid Plunge In Nvidia, AMD: Greed Index Remains In 'Extreme Fear' Zone
Via Benzinga
Healthcare Sector Update: MEDtech And Diagnostics
Via Talk Markets
Topics ETFs Stocks / Equities World Trade
Exposures Tariff
Stay informed with the top movers within the S&P500 index on Wednesday.
Via Chartmill
Stocks Sink As Powell Dismisses 'Fed Put' Safety Net, Gold Extends Massive Lead Over Nasdaq
Via Benzinga
Topics Economy World Trade
Exposures Interest Rates Tariff
Discover which S&P500 stocks are making waves on Wednesday.
Via Chartmill
Nvidia Drags Wall Street Down, Gold Defies Gravity Ahead Of Powell Remarks: What's Driving Markets Wednesday?
Via Benzinga
Abbott Laboratories (ABT) Shares Skyrocket, What You Need To Know
Via StockStory
Exposures COVID-19
Nasdaq Down Over 2%; Abbott Laboratories Posts Upbeat Earnings
Via Benzinga
Abbott Stock Rises On Strong Q1 Earnings: Retail’s In Wait-And-Watch Mode
Via Stocktwits
Topics Government
Exposures Political
Abbott Labs Clocks Q1 Profit Beat, CEO Says Diversification And Execution Enable Navigation During Uncertainty
Via Benzinga
Abbott Laboratories Dips As Sales Come In Light Despite Profit Beat
Via Investor's Business Daily
Abbott Laboratories (NYSE:ABT) Posts Q1 Sales In Line With Estimates
Via StockStory
Abbott Laboratories Reports Strong First Quarter Results, Maintains Positive Outlook
Via Talk Markets
Topics Stocks / Equities
US Stock Likely To Open Lower As US-China Tariff War Continues: 'Valuations Are Now Looking More Compelling,' Says Expert
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.